FDA Panel Recommends Pulling Preterm Birth Drug From the Market
The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.
Source: NYT Health - Category: Consumer Health News Authors: Christina Jewett Tags: Babies and Infants Pregnancy and Childbirth Premature Babies Drugs (Pharmaceuticals) Regulation and Deregulation of Industry Food and Drug Administration Source Type: news
More News: Babies | Food and Drug Administration (FDA) | Health | Perinatology & Neonatology | Pregnancy | Premature Birth | Study